Market Overview:
The global opthalmic pharmaceutical drugs market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of eye diseases, rising geriatric population, and technological advancements in ophthalmic drugs. The global opthalmic pharmaceutical drugs market is segmented on the basis of type into anti-glaucoma, anti-infection, anti-inflammatory, and anti-allergy drugs. The hospital pharmacies segment is expected to account for the largest share of the global opthalmic pharmaceuticals drugs market in 2018. This can be attributed to factors such as growing awareness about eye health among people and increasing number of hospitals worldwide.
Product Definition:
An ophthalmic pharmaceutical drug is a medication that is used to treat eye diseases or disorders. These drugs can be used to correct vision problems, relieve pain and inflammation, and fight infections. Ophthalmic pharmaceutical drugs are important because they can help improve the quality of life for people who suffer from eye diseases or disorders.
Anti-glaucoma:
Anti-glaucoma drugs are used to lower the pressure in the eye due to increased fluid volume. Glaucoma is a chronic, progressive disease that may result in permanent blindness if not treated. The treatment of choice for glaucoma is usually a drug called “antihistamine” which reduces the production of fluid by blocking certain chemical pathways.
Anti-infection:
Anti-infection is the treatment of microorganisms that are present in a harmful amount and/or are causing infections. Anti-infective drugs can be used for various ophthalmic diseases such as myopia, presbyopia, dry eyes, glaucoma, corneal ulcers and other infectious diseases. The most common types of anti-infective agents used in eye drops are antibiotics (e.g., Neosporin), antifungals (e.
Application Insights:
Based on application, the global market is segmented into hospital pharmacies, drug stores, online pharmacies and others. The hospital pharmacies held the largest share in 2017 as a result of high usage of pharmaceutical drugs for treating ocular diseases such as glaucoma and eye infections at hospitals.
The growing prevalence of ophthalmic diseases coupled with rising geriatric population is expected to boost demand for opthalmic pharmaceutical drugs over the forecast period. In addition, increasing government funding for research in this field is further anticipated to propel growth during future years.
The drug stores are anticipated to witness lucrative growth over the forecast period due to increase in awareness about availability of various treatment options other than surgery.
Regional Analysis:
North America dominated the global market in 2017. The presence of key players, favorable reimbursement policies, and high adoption rate for advanced treatment options are some of the factors responsible for its growth. Moreover, increasing prevalence of ophthalmic disorders is expected to drive regional growth over the forecast period. For instance, according to a study published by National Institutes of Health (NIH), in U.S., around 17 million people suffer from glaucoma out of which only 1% have been diagnosed so far.
Asia Pacific is expected to witness lucrative CAGR during the forecast period owing to rising healthcare expenditure and awareness regarding various treatment options among patients as well as physicians alike.
Growth Factors:
- Increasing prevalence of eye diseases and disorders: The increasing prevalence of various eye diseases and disorders is one of the key growth drivers for the ophthalmic pharmaceutical drugs market. According to a study by the World Health Organization (WHO), over 285 million people are affected by visual impairment, which is expected to increase to more than 380 million by 2020. This growing population base is likely to create significant demand for ophthalmic pharmaceutical drugs in the coming years.
- Rising awareness about eye health: There has been a rising awareness about eye health in recent years, owing to which people are increasingly seeking treatment for various eye-related problems at an early stage. This is another major factor that is driving growth in the ophthalmic pharmaceutical drugs market.
- Technological advancements: The advent of new technologies has led to significant advancements in ophthalmic surgical procedures, thereby providing patients with better outcomes post surgery. Such technological advances are also aiding manufacturers in developing novel drug formulations and delivery methods, thereby propelling growth in the global ophthalmic pharmaceutical drugs market .
Scope Of The Report
Report Attributes
Report Details
Report Title
Opthalmic Pharmaceutical Drugs Market Research Report
By Type
Anti-glaucoma, Anti-infection, Anti-inflammatory, Anti-allergy
By Application
Hospital Pharmacies, Drug Stores, Online Pharmacies, Others
By Companies
Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma, Topcon Corporation, Ziemer Ophthalmic Systems, Johnson & Johnson
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
200
Number of Tables & Figures
140
Customization Available
Yes, the report can be customized as per your need.
Global Opthalmic Pharmaceutical Drugs Market Report Segments:
The global Opthalmic Pharmaceutical Drugs market is segmented on the basis of:
Types
Anti-glaucoma, Anti-infection, Anti-inflammatory, Anti-allergy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital Pharmacies, Drug Stores, Online Pharmacies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Johnson & Johnson
- Carl-Zeiss
- Ellex Medical Lasers
- Essilor International
- Hoya Corporation
- Insight Vision
- Nidek
- Novagali Pharma
- Topcon Corporation
- Ziemer Ophthalmic Systems
- Johnson & Johnson
Highlights of The Opthalmic Pharmaceutical Drugs Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Anti-glaucoma
- Anti-infection
- Anti-inflammatory
- Anti-allergy
- By Application:
- Hospital Pharmacies
- Drug Stores
- Online Pharmacies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Opthalmic Pharmaceutical Drugs Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Opthalmic pharmaceutical drugs are medications used to treat eye conditions. These drugs can be prescribed by a doctor, and they may be available over the counter (OTC) in some countries. Some of these medications are used to treat things like glaucoma, macular degeneration, and cataracts.
Some of the major players in the opthalmic pharmaceutical drugs market are Johnson & Johnson, Carl-Zeiss, Ellex Medical Lasers, Essilor International, Hoya Corporation, Insight Vision, Nidek, Novagali Pharma, Topcon Corporation, Ziemer Ophthalmic Systems, Johnson & Johnson.
The opthalmic pharmaceutical drugs market is expected to grow at a compound annual growth rate of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Opthalmic Pharmaceutical Drugs Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Opthalmic Pharmaceutical Drugs Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Opthalmic Pharmaceutical Drugs Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Opthalmic Pharmaceutical Drugs Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Opthalmic Pharmaceutical Drugs Market Size & Forecast, 2020-2028
4.5.1 Opthalmic Pharmaceutical Drugs Market Size and Y-o-Y Growth
4.5.2 Opthalmic Pharmaceutical Drugs Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Anti-glaucoma
5.2.2 Anti-infection
5.2.3 Anti-inflammatory
5.2.4 Anti-allergy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital Pharmacies
6.2.2 Drug Stores
6.2.3 Online Pharmacies
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Opthalmic Pharmaceutical Drugs Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Opthalmic Pharmaceutical Drugs Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Anti-glaucoma
9.6.2 Anti-infection
9.6.3 Anti-inflammatory
9.6.4 Anti-allergy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital Pharmacies
9.10.2 Drug Stores
9.10.3 Online Pharmacies
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Anti-glaucoma
10.6.2 Anti-infection
10.6.3 Anti-inflammatory
10.6.4 Anti-allergy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital Pharmacies
10.10.2 Drug Stores
10.10.3 Online Pharmacies
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Anti-glaucoma
11.6.2 Anti-infection
11.6.3 Anti-inflammatory
11.6.4 Anti-allergy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital Pharmacies
11.10.2 Drug Stores
11.10.3 Online Pharmacies
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Anti-glaucoma
12.6.2 Anti-infection
12.6.3 Anti-inflammatory
12.6.4 Anti-allergy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital Pharmacies
12.10.2 Drug Stores
12.10.3 Online Pharmacies
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Anti-glaucoma
13.6.2 Anti-infection
13.6.3 Anti-inflammatory
13.6.4 Anti-allergy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital Pharmacies
13.10.2 Drug Stores
13.10.3 Online Pharmacies
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Opthalmic Pharmaceutical Drugs Market: Competitive Dashboard
14.2 Global Opthalmic Pharmaceutical Drugs Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Johnson & Johnson
14.3.2 Carl-Zeiss
14.3.3 Ellex Medical Lasers
14.3.4 Essilor International
14.3.5 Hoya Corporation
14.3.6 Insight Vision
14.3.7 Nidek
14.3.8 Novagali Pharma
14.3.9 Topcon Corporation
14.3.10 Ziemer Ophthalmic Systems
14.3.11 Johnson & Johnson
